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S72 Abstracts of the 7th International Congress of the Asia Pacific Society of Infection Control, Taipei, Taiwan, March 26-29, 2015Methods: A thorough search was done using the key terms “statin” and “hep-
atitis C.” Six RCTs were included with a total of 704 patients. The proportion
of patients achieving SVR was treated as dichotomous variables. Statistical
analysis was done using the Peto Method with fixed-effect analysis model,
and Peto odds ratio as effect measure. Weighted averages were reported
as relative risks with associated 95% confidence interval. Abstracted data
were then analyzed using Review Manager 5 program.
Results: Results showed that triple therapy with PEG IFN, RBV, and statin
was superior to standard therapy of PEG IFN and RBV in achieving SVR [RR
0.42 CI 95% (0.31, 0.57)] and RVR [RR 0.25 CI 95% (0.11, 0.58)]. No heteroge-
neity was found between studies for SVR(I2Z 0; PZ 0.80) and RVR (I2Z 0; P
Z 0.51).
Figure 1 Effect of PEG IFN+RBV+statin versus PEG IFN+RBV on SVR rate in pa-
tients with chronic hepatitis C. RR, relative risk; CI, confidence interval.
Conclusion: Statins are effective and safe as add-on therapy for chronic
hepatitis C.PS 1-043
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Purpose: Respiratory infections are major cause of pediatric burden in
ambulatory care. Understanding of how respiratory illness spreads through
communities is needed to inform control programs. Investigations into
age-related variations in seasonal trends, however, require large data with
high precision.
Methods: The study dataset is a nationally representative, random sample of
198,688 Taiwanese children aged 0e9 years from the 2005 National Health
Insurance Database. Weekly incidence of acute respiratory infection (ARI)
(ICD-9 codes 460e466) and pneumonia/influenza (P&I) (ICD-9 codes
480e488) were calculated and fitted in a sinusoidal model by age (in years),
with a fixed wavelength of one year, for the period 2000e2005. The time in
year where the peak incidence occurred was estimated from the sinusoidal
models, and compared among results from (1) individual-level analyses,
assuming the same sinusoidal models; and (2) epidemic midpoints, defined
as the time by which the cumulative incidence was 50% between the
-154th and +210th day (New Year as day 0).
Results: Mean incidence of ARI (209e250 per 1,000) and P&I (9e10 per 1,000)
were highest among children aged 0e4 years, above which each year older
was associated with lower mean incidence. We observed a significantly earlier
annual peak among children 4 years of age compared with younger and older
ages, for both ARI (week 1.6, 95% CI2.4 to 0.8) and P&I (week 1.0, 95% CI
0.3 to 2.3). The leading trends at age 4 years were confirmed by individual-
level sinusoidal models (week of peak incidence 1.6 [ARI] and 1.7 [P&I]) and
epidemic midpoints (week 2.1 [ARI] and 3.1 [P&I]).
Conclusions: Children 4 years of age presented for ARI or P&I earlier than
younger and older ages. Age-related differences in seasonal trends may
add insights into ARI and P&I transmissions.PS 1-044
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SHOCK IN A CRITICALLY ILL PATIENT CAUSED BY CMV PROCTITIS
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The cytomegalovirus (CMV) disease plays an important role in immuno-
compromised patients. As to the patients with critical illness, the
significance of CMV disease is not well understood. We reported an 83-
year-old woman, who underwent hemodialysis for diabetic nephropathy
with end-stage renal disease, was admitted due to urosepsis, following
massive lower gastrointestinal bleeding, which was related to
CMV infection and the response was dramatically good after use of
ganciclovir.PS 1-045
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Purpose: The aim of this study is to investigate the prevalence of HCV geno-
type (GT) and the change of GT in IVDU related HIV/HCV co-infection pa-
tients without receiving anti-HCV treatment.
Methods: From 2005 to 2012, a total of 71 cases of IVDU related HIV/HCV co-
infection were included. GT of HCV was determined by PCR targeting the
NS5B region and sequencing. The change of HCV GT in each case was deter-
mined in those who had paired blood sample available.
Results: All of the 71 cases had their first HCV GT determined from 2005 to
2009, including GT-1 (39.4%, 1a [26.7%] and 1b [12.7%]), GT-6 (22.5%, 6a
[19.7%], 6b [1.4%], and 6g [1.4%]), GT-3 (21.1%, 3a [19.7%] and 3b
[1.4%]), GT-2 (15.5%, 2a [4.2%] and 2b [11.3%]), and GT-5a (1.4%). Sixty-
eight (95.8%) cases had their second HCV GT determined from 2010 to
2012, including GT-1 (47.1%, 1a [33.9%] and 1b [13.2%]), GT-6 (22.1%, 6a
[20.6%] and 6g [1.5%]), GT-3 (20.6%, 3a [19.1%] and 3b [1.5%]), and GT-2
(10.2%, 2a [2.9%] and 2b [7.3%]). The mean duration between the first
and second test was 1809  467 days. Twenty (29.4%) case had change
of HCV GT. The frequency of change of each GT were 6/10 (60.0%) of
GT-2, 5/15 (33.3%) of GT-3, 5/15 (33.3%) of GT-6, 3/27 (11.1%) of GT-1,
and 1/1 (100%) of GT-5. Eight (19.5%) of 41 non-GT-1 cases had changed
to GT-1.
Conclusions: Near 30% of IVDU related HIV/HCV co-infection cases have
change of HCV GT without anti-HCV treatment.PS 1-046
WHAT ARE YOU BRINGING HOME e HELPING THE HEALTHCARE WORKER
PROTECT THEIR FAMILY FROM DISEASE, INFORMATION AND ADVICE
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Health care-associated infections are a common problem globally. Health
care workers (HCW) and patients are at high risk of acquiring the
infections, and also transmitting the infections. Most studies identified
risks of doctors and nurses with direct contact with patients but not many
study concentrate on the risk of HCW with indirect contact with patients,
especially environmental services staffs/housekeeping staffs. These
workers are in contact with the patients indirectly, and have been
overlooked in the risk assessment. These workers, in addition to the
doctors and nurses may act as reservoir and transmit the disease to their
family members, spreading the infections unknowingly. Most of the
infections are transferred through contact, direct and/or indirect, from
surfaces contaminated with the microorganisms. This presentation will
highlight the mode of transmission from the obvious surfaces such as
patient’s table to the less obvious mode such as the air in the room of an
infected patient after/during house-keeping. This presentation will also
identify the most vulnerable family members and provide a step-by-step
